Autoimmune Phenomena in Patients with Myelodysplastic Syndromes

References

• Bennett J. M., Catovsky D., Daniel M. T., Flandrin G., Galton D. A. G., Gralnick H. R., Sultan C. The French-American-British (FAB) Cooperative Group. Proposals for the classification of the myelodysplastic syndromes. British Journal of Haematology 1982; 51: 189–199
   PubMed Web of Science ®Google Scholar
• Mufti G. J., Figes A., Hamblin T. J., Oscier D. G., Cobblestone J. A. Immunological abnormalities in myelodysplastic syndromes. I. Serum immunoglobulins and autoantibodies. British Journal of Haematology 1986; 63: 143–147
   PubMed Web of Science ®Google Scholar
• Colombat P. H., Renoux M., Lamagnere J. P., Renoux G. Immunologic indices in myelodysplastic syndromes. Cancer 1988; 61: 1075–1081
   PubMed Web of Science ®Google Scholar
• Green A. R., Shuttleworth D., Bowen D. T., Bentley D. P. Cutaneous vasculitis in patients with myelodysplasia. British Journal of Haematology 1990; 74: 364–365
   PubMed Web of Science ®Google Scholar
• Marullo S., Dallot A., Cavelier-Balloy B., Valensi F., Clauvel J. P. Subcutaneous eosinophilic necrosis associated with refractory anemia with an excess of myeloblasts. Journal of the American Academy of Dermatology 1989; 120: 320–323
   Web of Science ®Google Scholar
• Pagliuca A., Higgins E., Samson D., Humphries S., Mufti G. J. Prodromal cutaneous vasculitis in myelodysplastic syndromes. British Journal of Haematology 1990; 75: 444–446
   PubMed Web of Science ®Google Scholar
• Doutre M. S., Beylot J., Beylot C., Courouge-Dorcier D., Reiffers J., Broustet A., Bioulac-Sage P. Refractory anemia with an excess of blasts and cutaneous vasculitis. Annals of Dermatology and Venereology 1987; 114: 97–100
   PubMed Web of Science ®Google Scholar
• Savige J. A., Chang L., Smith C. L., Duggan J. C. Myelodysplasia, vasculitis and anti-neutrophil cytoplasm antibodies. Leukemia and Lymphoma 1993; 9: 49–54
   PubMed Web of Science ®Google Scholar
• George S. W., Newman E. D. Seronegative inflammatory arthritis in the myelodysplastic syndromes. Seminars in Arthritis and Rheumatism 1992; 21: 345–354
   PubMed Web of Science ®Google Scholar
• Castro M., Conn D. L., Su W. P., Garton J. P. Rheumatic manifestations in myelodysplastic syndromes. Journal of Rheumatology 1992; 18: 721–727
   Web of Science ®Google Scholar
• Enright H., Jacob H. S., Vercellotti G., Howe R., Belzer M., Miller W. Paraneoplastic autoimmune phenomena in patients with myelodysplastic syndromes: response to immunosuppressive therapy. British Journal of Haematology 1995; 91: 403–408
   PubMed Web of Science ®Google Scholar
• Ramakrishna R., Chaudhuri K., Sturgess A., Manoharan A. Haematological manifestations of primary Sjögren's syndrome: a clinicopathological study. Quarterly Journal of Medicine 1992; 83: 547–554
   PubMedGoogle Scholar
• McGill J., Michet C., Goldberg J., Pedell L., McAdam L. Relapsing polychondritis and hematopoietic disease in 11 patients. Arthritis and Rheumatism 1986; S39: 1898
   Google Scholar
• Hebbar M., Brouillard M., Wattel E., Decoulx M., Hatron P-Y., Devulder B., Fenaux P. Association of myelodysplastic syndrome and relapsing polychondritis: further evidence. Leukemia 1995; 9: 731–733
   PubMed Web of Science ®Google Scholar
• Ng H. S., Ng H. W., Sinniah R., Feng P. H. A case of systemic lupus erythematosus with sideroblastic anaemia terminating in erythroleukaemia. Annals of the Rheumatic Diseases 1981; 40: 422–426
   PubMed Web of Science ®Google Scholar
• Tallman M. S., McGuffin R. W., Higano C. S., Starkebaum G., Collins S. J., Johnston H., Singer J. W., Perry D. J., Kunath A. Bone marrow transplantation in a patient with myelodysplasia associated with diffuse eosinophilic fasciitis. American Journal of Hematology 1987; 24: 93–99
   PubMed Web of Science ®Google Scholar
• Perry H. O., Winkelmann R. K. Bullous pyoderma gangrenosum and leukemia. Archives of Dermatology 1972; 106: 901–905
   PubMed Web of Science ®Google Scholar
• Fernandez-Miranda C., Garcia-Marcilla A., Martin M., Gil R., Vanaclocha F., Torres N., del Palacio A. Vasculitis associated with a myelodysplastic syndrome: a report of 5 cases. Medicina Clinica 1994; 103: 539–542
   PubMed Web of Science ®Google Scholar
• Rosenthal N. S., Farhi D. C. Bone marrow findings in connective tissue disease. American Journal of Clinical Pathology 1989; 92: 650–654
   PubMed Web of Science ®Google Scholar
• Feng C. S., Ng M. H., Szeto R. S., Li E. K. Bone marrow findings in lupus patients with pancytopenia. Pathology 1991; 23: 5–7
   PubMed Web of Science ®Google Scholar
• Sokol R. J., Hewitt S., Booker D. J. Erythrocyte autoantibodies, autoimmune haemolysis, and myelodysplastic syndromes. Journal of Clinical Pathology 1989; 42: 1088–1091
   PubMed Web of Science ®Google Scholar
• Stadtmauer E. A. Danazol treatment of myelodysplastic syndromes. British Journal of Haematology 1991; 77: 502–508
   PubMed Web of Science ®Google Scholar
• Miescher P. A., Favre H., Beris P. Autoimmune myelodysplasias. Seminars in Hematology 1991; 28: 322–330
   PubMed Web of Science ®Google Scholar
• Economopoulos T., Economidou J., Giannopoulos G., Terzoglou C., Papageorgiou E., Dervenoulas J., Arseni P., Hadjioannou J., Raptis S. Immune abnormalities in myelodysplastic syndromes. Journal of Clinical Pathology 1985; 38: 908–911
   PubMed Web of Science ®Google Scholar
• Billstrom R., Johansson H., Johansson B., Mitelman F. Immune-mediated complications in patients with myelodysplastic syndromes—clinical and cytogenetic features. European Journal of Haematology 1995; 55: 42–48
   PubMed Web of Science ®Google Scholar
• Bagby G. C., Gabourel J. D., Linman J. W. Glucocorticoid therapy in the preleukemic syndrome (hemopoietic dysplasia) identification of responsive patients by in vitro techniques. Annals of Internal Medicine 1980; 92: 55–58
   PubMed Web of Science ®Google Scholar
• Karcher D. S., Frost A. R. The bone marrow in human immunodeficiency virus (HIV)-related disease. Morphology and clinical correlation. American Journal of Clinical Pathology 1991; 95: 63–71
   PubMed Web of Science ®Google Scholar
• Felzmann T., Gisslinger H., Ludwig H. Immunological findings in patients with myelodysplastic syndrome. Leukemia and Lymphoma 1994; 15: 201–208
   PubMed Web of Science ®Google Scholar
• Finkel H. E., Brauer M. K., Taub R. N., Dameshek W. Immunologic aberrations in the Di Guglielmo syndrome. Blood 1966; 28: 634–649
   PubMed Web of Science ®Google Scholar
• Ayanlar-Batuman O., Shevitz J., Traub U. C., Murphy S., Sajewski D. Lymphocyte interleukin-2 production and responsiveness are altered in patients with primary myelodysplastic syndrome. Blood 1987; 70: 494–500
   PubMed Web of Science ®Google Scholar
• Kerndrup G., Meger K., Ellegaard J., Hokland P. Natural killer (NK)-cell activity and antibody-dependent cellular cytotoxicity (ADCC) in primary preleukaemic syndrome. Leukaemia Research 1984; 8: 239–247
   PubMed Web of Science ®Google Scholar
• Anzai T., Hirose W., Nakane H., Kawagoe M., Kawai T., Watanabe K. Myelodysplastic syndrome associated with immunoblastic lymphadenopathy-like T-cell lymphoma: Simultaneous clinical improvement with chemotherapy. Japanese Journal of Clinical Oncology 1994; 24: 106–110
   PubMed Web of Science ®Google Scholar
• Penas P. F., Jones-Caballero M., Dauden E., Fraga J., Garcia-Diez A. Cutaneous T-cell lymphoma and myelodysplastic syndrome. Journal of the American Academy of Dermatology 1994; 31: 1065–1067
   PubMed Web of Science ®Google Scholar